Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states

Journal of Internal Medicine

Volumn 271, Issue 4, 2012, Pages 414-420

  Ryden M ^a   Agustsson, T ^a   Andersson, J ^b   Bolinder, J ^a   Toft, E ^a,c   Arner, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ERSTA HOSPITAL   (Sweden)

Author keywords

Adipocyte; Cachexia; Cancer; Nutrition; Obesity; Secretion

Indexed keywords

ALPHA2 GLYCOPROTEIN; FATTY ACID; GLYCEROL; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADULT; AGED; ARTICLE; BODY MASS; CACHEXIA; CALORIC RESTRICTION; CANCER PATIENT; CATABOLISM; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CULTURE MEDIUM; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FATTY ACID BLOOD LEVEL; FEMALE; GALLBLADDER CANCER; GLYCEROL BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LOW CALORY DIET; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RESPIRATORY QUOTIENT; STOMACH CANCER; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CACHEXIA; FATTY ACIDS, NONESTERIFIED; FEMALE; GASTROINTESTINAL NEOPLASMS; GLYCEROL; HUMANS; MALE; METABOLISM; MIDDLE AGED; NEOPLASMS; OBESITY; SEMINAL PLASMA PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858860710     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02441.x     Document Type: Article

References (26)

1. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89: 381-410.
2. Ryden M, Arner P. Fat loss in cachexia - is there a role for adipocyte lipolysis? Clin Nutr 2007; 26: 1-6.
3. Evans WJ, Morley JE, Argiles J et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-9.
4. Ryden M, Agustsson T, Laurencikiene J et al. Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia. Cancer 2008; 113: 1695-704.
5. Agustsson T, Ryden M, Hoffstedt J et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res 2007; 67: 5531-7.
6. Tisdale MJ. Zinc-alpha2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care 2009; 3: 288-93.
7. Bing C, Mracek T, Gao D, Trayhurn P. Zinc-alpha2-glycoprotein: an adipokine modulator of body fat mass? Int J Obes (Lond) 2010; 34: 1559-65.
8. Mracek T, Stephens NA, Gao D et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 2011; 104: 441-7.
9. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996; 12: S15-9.
10. Hagstrom-Toft E, Thorne A, Reynisdottir S et al. Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 2001; 50: 1604-11.
11. Dahlman I, Kaaman M, Olsson T et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005; 90: 5834-40.
12. Coppack SW, Fisher RM, Gibbons GF et al. Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci (Lond) 1990; 79: 339-48.
13. Frayn KN, Coppack SW. Assessment of white adipose tissue metabolism by measurement of arteriovenous differences. Methods Mol Biol 2001; 155: 269-79.
14. Sobin L, Wittekind C. TNM classification of malignant tumours. In: IUAC, ed. UICC. New Jersey: John Wiley & Sons, 2002; 1-272.
15. Kolaczynski JW, Morales LM, Moore Jr JH et al. A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. Int J Obes Relat Metab Disord 1994; 18: 161-6.
16. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-80.
17. Mejhert N, Galitzky J, Pettersson AT et al. Mapping of the fibroblast growth factors in human white adipose tissue. J Clin Endocrinol Metab 2010; 95: 2451-7.
18. Capel F, Klimcakova E, Viguerie N et al. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes 2009; 58: 1558-67.
19. Ceperuelo-Mallafre V, Naf S, Escote X et al. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab 2009; 94: 5062-9.
20. Dahlman I, Mejhert N, Linder K et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer 2010; 102: 1541-8.
21. Marrades MP, Martinez JA, Moreno-Aliaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 2008; 64: 61-6.
22. Selva DM, Lecube A, Hernandez C, Baena JA, Fort JM, Simo R. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009; 94: 4499-507.
23. Mracek T, Ding Q, Tzanavari T et al. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 2010; 72: 334-41.
24. Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 2009; 94: 2531-6.
25. Stejskal D, Karpisek M, Reutova H, Stejskal P, Kotolova H, Kollar P. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008; 41: 313-6.
26. Gong FY, Zhang SJ, Deng JY et al. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond) 2009; 33: 1023-30.